Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchor Anne Mostue are joined by top names from local business and finance to medicine and politics, along with Bloomberg reporters covering the latest stories in and around Boston. Today: Adam Gridley, CEO of Histogenics, on rebuilding knee cartilage and taking the company public. Bloomberg Biotech Reporter Doni Bloomfield and Anne Mostue talk to Jeff Greene, Global Transactions Leader for Life Sciences at Ernst and Young, about why the biotech M+A scene has been so quiet after talk of a boom. And Ken Shea, Bloomberg Intelligence Senior Industry Analyst, explains why the beer industry is suffering this summer.
Running time 38:19